Alfida Tablets
PDF Leaflet Revision Date: 22 September 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV-1 infection in adults and pediatric patients u2265 40 kg.
Dosage (summary)
One tablet once daily, with or without food.
Special Populations
- Elderly patients
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Avoid with dofetilide, pilsicainide, metformin, and other tenofovir/emtricitabine-containing medicines.
- Caution with antacids containing polyvalent cations.
Contraindications
- Hypersensitivity to components
- Moderate/severe hepatic impairment
- Severe renal impairment (CrCl < 30 mL/min)
Common side effects
- Nausea
- Fatigue
- Insomnia
- Headache
Counselling Points
- Monitor for signs of liver toxicity.
- Use effective contraception during treatment.
- Regularly check renal function.
Serious warnings
- Hypersensitivity reactions
- Lactic acidosis
- Severe hepatotoxicity
- Immune reconstitution syndrome
Important Disclaimer
The Alfida Tablets professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
